Watson Fund: Funding, Team & Investors | Startup Intros

Loading organizations...

Watson Fund: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2024	Proniras	$5.0M Series B	ARCH Venture Partners, Thong Le	Deerfield Management, Anthony Philippakis, WRF Capital
Aug 13, 2018	Magnolia NeuroSciences	$31.0M Series A	—	180 Degree Capital, AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, WuXi AppTec
Jul 25, 2017	Rodeo Therapeutics	$5.9M Series A	—	AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation, WRF Capital, WuXi AppTec
Dec 12, 2016	ApoGen Biotechnologies	$7.0M Series A	—	AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, AvB Ventures, Eli Lilly and Company, Johnson & Johnson Innovation, WRF Capital, WuXi AppTec
Jan 11, 2016	Lodo Therapeutics	$17.0M Series A	—	AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Trevor Mundel, Eli Lilly and Company, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, WuXi AppTec
Jan 6, 2016	Petra Pharma	$48.0M Series A	—	AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Greg Plowman, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Innovation, Partnership Fund for New York City, WuXi AppTec